Cargando…
A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease
Alzheimer’s disease (AD), the most common type of dementia, is an ageing-related progressive neurodegenerative brain disorder. Extracellular neuritic plaques composed of misfolded amyloid β (Aβ) proteins and intracellular neurofibrillary tangles formed by hyperphosphorylated tau protein are the two...
Autores principales: | Yang, Zhiyou, Liu, Junxin, Wei, Shuai, Deng, Jiahang, Feng, Xinyue, Liu, Shucheng, Liu, Mingxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868240/ https://www.ncbi.nlm.nih.gov/pubmed/36699095 http://dx.doi.org/10.3389/fphar.2022.1077222 |
Ejemplares similares
-
A review for discovering bioactive minor saponins and biotransformative metabolites in Panax quinquefolius L.
por: Yang, Zhiyou, et al.
Publicado: (2022) -
Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
por: Ding, Nan, et al.
Publicado: (2020) -
Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout
por: Lee, Jun Ho, et al.
Publicado: (2022) -
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
por: Liang, Tao, et al.
Publicado: (2022) -
Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD
por: Huang, Qian, et al.
Publicado: (2022)